Identification of druggable cancer driver genes amplified across TCGA datasets.
The Cancer Genome Atlas (TCGA) projects have advanced our understanding of the driver mutations, genetic backgrounds, and key pathways activated across cancer types. Analysis of TCGA datasets have mostly focused on somatic mutations and translocations, with less emphasis placed on gene amplification...
Guardado en:
Autores principales: | Ying Chen, Jeremy McGee, Xianming Chen, Thompson N Doman, Xueqian Gong, Youyan Zhang, Nicole Hamm, Xiwen Ma, Richard E Higgs, Shripad V Bhagwat, Sean Buchanan, Sheng-Bin Peng, Kirk A Staschke, Vipin Yadav, Yong Yue, Hosein Kouros-Mehr |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a29e5a4806f34d02a21d59875c6c8e59 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
KRAS mutation: from undruggable to druggable in cancer
por: Lamei Huang, et al.
Publicado: (2021) -
On the reproducibility of TCGA ovarian cancer microRNA profiles.
por: Ying-Wooi Wan, et al.
Publicado: (2014) -
Genomic alterations and possible druggable mutations in carcinoma of unknown primary (CUP)
por: Hamidreza Aboulkheyr Es, et al.
Publicado: (2021) -
Discovery analysis of TCGA data reveals association between germline genotype and survival in ovarian cancer patients.
por: Rosemary Braun, et al.
Publicado: (2013) -
Gene essentiality landscape and druggable oncogenic dependencies in herpesviral primary effusion lymphoma
por: Mark Manzano, et al.
Publicado: (2018)